Brokers Set Expectations for OTC:GTBIF FY2024 Earnings

Green Thumb Industries Inc. (OTC:GTBIF) – Roth Capital issued their FY2024 earnings per share (EPS) estimates for Green Thumb Industries in a report released on Sunday, November 10th. Roth Capital analyst W. Kirk anticipates that the company will post earnings of $0.32 per share for the year. Roth Capital currently has a “Strong-Buy” rating on the stock. The consensus estimate for Green Thumb Industries’ current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries’ Q4 2024 earnings at $0.07 EPS, Q1 2025 earnings at $0.07 EPS, Q2 2025 earnings at $0.08 EPS, Q3 2025 earnings at $0.07 EPS, Q4 2025 earnings at $0.08 EPS and FY2025 earnings at $0.30 EPS.

GTBIF has been the subject of several other reports. Craig Hallum raised shares of Green Thumb Industries to a “strong-buy” rating in a research report on Monday, September 16th. Ventum Cap Mkts upgraded shares of Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th.

Green Thumb Industries Stock Down 4.2 %

OTC GTBIF opened at $9.29 on Wednesday. The stock has a market cap of $1.97 billion, a P/E ratio of 34.42 and a beta of 1.40. Green Thumb Industries has a one year low of $7.50 and a one year high of $16.33. The firm’s 50-day simple moving average is $10.24.

Green Thumb Industries Company Profile

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.